Earlier in his career, he served as CFO at multiple publicly-traded biotech companies including Sirna Therapeutics, a genetic ...

Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the appointment of Greg Weaver as Chief Financial Officer ...

[17] Nanotechnology-based methods of drug delivery across the BBB include two commercialized technologies LipoBridge™ (Genzyme Pharmaceuticals, MA, USA) and G-Technology® (to-BBB, Leiden ...